Long lasting cosmetic compositions

Information

  • Patent Grant
  • 12048760
  • Patent Number
    12,048,760
  • Date Filed
    Friday, April 26, 2019
    5 years ago
  • Date Issued
    Tuesday, July 30, 2024
    3 months ago
Abstract
Provided are hair treatment compositions comprising a polyurethane-urea crosslinked by at least one multi-functional chain extender, and uses thereof.
Description
RELATED APPLICATIONS

This application is a § 371 national stage filing of PCT/US2019/029274, filed Apr. 26, 2019, which claims priority to U.S. Provisional Application No. 62/663,315, filed Apr. 27, 2018, the entire contents of each of which are incorporated herein by reference.


BACKGROUND

Polyurethanes and polyurethane-ureas are a well-known class of synthetic polymers with broad utility in multiple industries. This versatility is derived from the ability to prepare polyurethanes from a large and diverse set of potential monomers. These diverse monomer options allow the realization of an equally diverse set of physical properties. Hence, the resulting polyurethanes can be in many different forms including e.g., soft foams, elastomers, adhesive films, or hard plastics, and can be used in many different types of products including bedding, foot wear, adhesives, and automobile parts.


Among these many forms of polyurethanes, waterborne polyurethanes (WBPUs) and polyurethane-ureas (WBPU-Us) have been used as film forming agents in commercially available personal care products. When used as hair fixatives, these film forming polymers provide style-holding benefits. The problem with the use of WBPUs and WBPU-Us for consumer-based cosmetic products has been the lack of performance and overall consistency in application. For example, common polyurethane products such as Luviset® P.U.R, DynamX, and DynamX H2O lack elasticity. This leads to an undesirable stiff feeling when applied to hair. Avalure UR 405, Baycusan C1004, Baycusan C1008, and Polyderm PE/PA ED, however, are very flexible (i.e., do not lack elasticity). Yet, these products have poor initial curl hold and elicit a gummy feeling. Other problems associated with the use of WBPUs and WBPU-Us include, but are not limited to, flaking upon touching or combing (e.g., dusty micro-flakes shown on hair fibers); undesirable tactile feelings upon touch (e.g., brittle, stiff, or tacky, gummy); poor humidity resistance (e.g., styling resins absorb moisture and weigh down hair resulting in a loss of style); lack of movement (e.g., plastic-like mold shape; hair curls don't move with motion; can't easily comb through; gummy; lack of bounciness); and short-lived hair styles (e.g., hair styles, curls, waves, etc. don't last long—on average styles typically last less than a half day).


Previously, we identified a combination of selection markers that could be used to determine whether certain WBPU based cosmetic compositions, such as hair fixatives, would result in improved performance. See WO 2017/155906 the entire contents of which are incorporated herein by reference. In one aspect, e.g., we have shown that compositions comprising WBPUs having a Young's modulus above 150 MPa, an elongation at break from about 15% to about 300%, and a moisture uptake of less than 10%, provide long-lasting and natural hairstyles. See WO 2017/155906. Here, we focus on improving the mechanical properties while maintaining a moisture uptake of less than 10%, which was previously demonstrated to be optimal for achieving long-lasting styling performance.


SUMMARY

It has now been found that the long-lasting characteristics arising from WBPUs possessing our previously disclosed combination of mechanical properties can by further enhanced by incorporating at least one multi-functional chain extender (such as a triol or tetraol) into the composition. Provided herein, therefore, are hair treatment compositions comprising a polyurethane-urea crosslinked by at least one multi-functional chain extender such as a hydrocarbon based triol or tetraol, wherein the Young's modulus of the polyurethane-urea is above 150 MPa; the elongation at break of the polyurethane-urea is from about 15% to about 300%; and the moisture uptake of the polyurethane-urea is less than 10%. In one aspect, the use of these multi-functional chain extenders provided hair compositions with better hold and stronger humidity resistance over those previously described. See e.g., FIG. 1, which shows a comparison of the in vivo performance of PU 419, an inventive WBPU crosslinked by multi-functional chain extender, with a commercial resin. As shown, PU 419 displays better initial hold and stronger humidity resistance.


It has also been found that incorporating nanoparticles into WBPU-based compositions possessing the proper combination of mechanical properties described above further improve the long-lasting effects of WBPUs in hair treatment products. Thus, in another aspect, also provided herein are hair treatment compositions comprising a polyurethane-urea and at least one nanoparticle, wherein the Young's modulus of the polyurethane-urea is above 150 MPa; the elongation at break of the polyurethane-urea is from about 15% to about 300%; and the moisture uptake of the polyurethane-urea is less than 10%. These compositions were found to outperform commercial resins in both initial curl hold and curl retention after high humidity stress. See e.g., FIG. 2, which shows a comparison of the in vitro performance of PU 427, an inventive WBPU/silica nanocomposite synthesized by in situ polymerization, with a commercial resin and comparator PU 339. As shown, PU 427 displays better initial hold and stronger humidity resistance. In addition, FIG. 4 shows the in vitro curl retention under 75% relative humidity for 15 minutes of PU 339 following post-blend with 1% Aerosil 200 (silica nanoparticles) or 0.25% TiO2. As shown, PU 339 post-blend with nanoparticles showed better initial curl hold and curl retention after high humidity. Taken together, this data shows that the disclosed nanocomposite technology applies generally to compositions comprising a polyurethane-urea having the disclosed mechanical properties, and is not limited to only those which comprise a multi-functional chain extender.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows the in vivo performance of a WBPU crosslinked by multi-functional chain extender of the present disclosure (PU 419) compared to a commercial resin.



FIG. 2 shows the in vitro performance of a WBPU/silica nanocomposite of the present disclosure synthesized by in situ polymerization (PU 427) compared to a commercial resin and comparator PU 339.



FIG. 3 shows the in vivo performance between PU 427 and comparator PU 339.



FIG. 4 shows the in vitro curl retention under 75% relative humidity for 15 minutes of comparator PU 339 following post-blend with 1% Aerosil 200 (silica nanoparticles) or 0.25% TiO2.





DETAILED DESCRIPTION
1. Definitions

As used herein, “cationic polyurethanes” refer to thermoplastic polymers comprising carbamate (urethane) groups and which bear an overall net positive charge at pH≤7. “Cationic polyurethane-ureas” refer to thermoplastic polymers comprising a —O—C(O)—NR— and a —NR—C(O)—NR-linkage and which bear an overall net positive charge at pH≤7. In some aspects, the cationic polyurethanes and cationic polyurethane-ureas described herein bear an overall net positive charge at pH from about 3.7 to about 6.5, from about 3.7 to about 6.0, or from about 3.7 to about 5.5. Unless otherwise specified, cationic polyurethanes and cationic polyurethane-ureas, when used herein, include amphoteric/cationic polyurethanes and polyurethane-ureas. In one aspect, however, cationic polyurethanes and cationic polyurethane-ureas do not encompass amphoteric/cationic polyurethanes or amphoteric/cationic polyurethane-ureas.


As used herein, “amphoteric polyurethanes” refer to thermoplastic polymers comprising carbamate (urethane) groups and which can act both as a cationic or an anionic polyurethanes depending on neutralization method. “Amphoteric polyurethane-ureas” refer to thermoplastic polymers comprising a —O—C(O)—NR— and a —NR—C(O)—NR-linkage and which can act both as a cationic or an anionic polyurethanes depending on neutralization method. An “amphoteric/cationic polyurethane” or “amphoteric/cationic polyurethane-urea” means that the described amphoteric species is one which acts as a cationic polyurethane or cationic polyurethane-urea when neutralized with an acid. An “amphoteric/anionic polyurethane” or “amphoteric/anionic polyurethane-urea” means that the described amphoteric species is one which acts as an anionic polyurethane or anionic polyurethane-urea when neutralized with a base.


As used herein, “anionic polyurethanes” refer to thermoplastic polymers comprising carbamate (urethane) groups and which bear an overall net negative charge at pH≥7. “Anionic polyurethane-ureas” refer to thermoplastic polymers comprising a —O—C(O)—NR— and a —NR—C(O)—NR-linkage and which bear an overall net negative charge at pH≥7. Unless otherwise specified, anionic polyurethanes and anionic polyurethane-ureas, when used herein, include amphoteric/anionic polyurethanes and amphoteric/anionic polyurethane-ureas. In one aspect, however, anionic polyurethanes and anionic polyurethane-ureas do not encompass amphoteric/anionic polyurethanes or amphoteric/anionic polyurethane-ureas.


“Young's modulus (or the modulus of elasticity, tensile modulus)” is a measure of the stiffness of a solid polymer film. Young's modulus, E, can be calculated by dividing the tensile stress by the extensional strain in the elastic (initial, linear) portion of the stress-strain curve. The Young's modulus of the waterborne polyurethanes and waterborne polyurethane-ureas can be determined by a protocol defined to measure mechanical properties, and is developed in reference to ASTM D638, ASTM D412, test guidelines as described below in Example 1.


The “elongation at break (also known as fracture strain, ultimate elongation)” is the ratio between changed length and initial length after breakage of the solid polymer film. The elongation at break of the waterborne polyurethanes and waterborne polyurethane-ureas can be determined by a protocol defined to measure mechanical properties, and is developed in reference to ASTM D638, ASTM D412, test guidelines as described below in Example 1.


The “moisture uptake” is the measure of water adsorbed by the solid polymer film. The method for determining the moisture uptake of the solid polymer film is provided in Example 2.


A “sensory score” may be determined by the performance of the hair fixative. In one aspect, the tress with the composition applied is blow dried for 90 seconds. The tresses are prepared in duplicate and blinded randomly and evaluated for natural feeling and overall sensory attributes on a scale of −2 to 2 by trained sensory analysts under blinded conditions. Sensory analysts are licensed hair stylists and cosmetic scientists with significant long-term experience evaluating sensory attributes of hair. Sensory analysts assign a score of −2 to tresses deemed entirely undesirable, a score of +2 to entirely soft, natural feeling and appearing hair, and intermediate scores between these two extremes.


The term “alkyl” refers to a monovalent saturated hydrocarbon group. C1-C6 alkyl is an alkyl having from 1 to 6 carbon atoms. An alkyl may be linear or branched. Examples of alkyl groups include methyl; ethyl; propyl, including n-propyl and isopropyl; butyl, including n-butyl, isobutyl, sec-butyl, and t-butyl; pentyl, including, for example, n-pentyl, isopentyl, and neopentyl; and hexyl, including, for example, n-hexyl and 2-methylpentyl.


2. Selection Markers

Provided herein are specific combinations of WBPU-U properties that have been found to result in cosmetic compositions (e.g., hair products) having substantially improved performance. Those properties include e.g., a combination of certain mechanical properties, a combination of certain chemical properties, or a combination of both mechanical and chemical properties.


Young's Modulus, Elongation at Break, and Moisture Uptake

The combination of mechanical properties described herein include the Young's modulus (e.g., above 150 MPa), the elongation at break (e.g., from about 15% to about 300%), and hydrophobicity (moisture uptake, e.g., less than 10%).


In one aspect, the Young's modulus of the polyurethane-urea described herein should be above about 150 MPa. For example, the Young's modulus of the polyurethane-urea in the disclosed compositions may be above about 160 MPa, above about 170 MPa, above about 180 MPa, above about 190 MPa, above about 200 MPa, above about 210 MPa, above about 220 MPa, above about 230 MPa, above about 240 MPa, above about 250 MPa, above about 260 MPa, above about 270 MPa, above about 280 MPa, above about 290 MPa, above about 300 MPa, above about 310 MPa, above about 320 MPa, above about 330 MPa, above about 340 MPa, above about 350 MPa, above about 360 MPa, above about 370 MPa, above about 380 MPa, above about 390 MPa, above about 400 MPa, above about 410 MPa, above about 420 MPa, above about 430 MPa, above about 440 MPa, above about 450 MPa, above about 460 MPa, above about 470 MPa, above about 480 MPa, above about 490 MPa, above about 500 MPa, above about 510 MPa, above about 520 MPa, above about 530 MPa, above about 540 MPa, or above 550 MPa. In other aspects, the Young's modulus of the polyurethane-urea should be between about 150 MPa and about 500 MPa. For example, the Young's modulus of the polyurethane-urea in the disclosed compositions may be between about 150 MPa and about 400 MPa, between about 150 MPa and about 350 MPa, between about 170 MPa and about 390 MPa, between about 180 MPa and about 320 MPa, between about 190 MPa and about 300 MPa, between about 200 MPa and about 290 MPa, or between about 210 MPa and about 280 MPa.


In one aspect, the elongation at break of the polyurethane-urea in the disclosed compositions should be from about 15% to about 300%. For example, the elongation at break of the polyurethane-urea in the disclosed compositions may be from about 20% to about 300%, from about 25% to about 300%, from about 40% to about 280%, from about 100% to about 280%, from about 100% to about 250%, from about 150% to about 250%, from about 200% to about 250%, from about 210% to about 250%, about 30% to about 150%, from about 15% to about 150%, from about 150% to about 300%, from about 50% to about 250%; from about 75% to about 225%, or from about 100% to about 200%. The elongation break may be optionally combined with one or more of the Young's modulus values described in the paragraph above or any one of the Young's modulus values described in the remainder of the disclosure.


In one aspect, the moisture uptake of the polyurethane-urea in the disclosed compositions should be less than about 10%. For example, the moisture uptake of the polyurethane-urea in the disclosed compositions may be less than about 9.5%, less than about 9%, less than about 8.5%, less than about 8%, less than about 7.5%, less than about 7%, less than about 6.5%, less than about 6%, less than about 5.5%, less than about 5%, less than about 4.5%, less than about 4%, less than about 3.5%, less than about 3%, less than about 2.5%, less than about 2%, less than about 1.5%, less than about 1%, less than about 0.5%, or is about 0%. In one aspect, the moisture uptake of the polyurethane-urea in the disclosed compositions should be from about 0% to about 10%. For example, the moisture uptake may be from about 0% to about 8%, from about 2% to about 8%, or from about 3% to about 7%. The moisture uptake may be optionally combined with one or more of the Young's modulus values, one or more of the elongation break values, or both as described in the paragraphs above or in the remainder of the disclosure.


As shown in the Exemplification section below, polyurethane-ureas having the Young's modulus, elongation at break, and moisture uptake described above improve initial hold and display better curl retention under high humidity.


3. Compositions

In a first embodiment, provided herein are hair fixative compositions comprising a polyurethane-urea crosslinked by at least one hydrocarbon based triol or tetraol, wherein the Young's modulus of the polyurethane-urea is above 150 MPa; the elongation at break of the polyurethane-urea is from about 15% to about 300%; and the moisture uptake of the polyurethane-urea is less than 10%.


In a second embodiment, the polyurethane-urea described in the composition of the first embodiment is anionic.


In a third embodiment, the polyurethane-urea described in the composition of the first or second embodiment is a salt of the formula: [Q, W, V, Y and Z]X, wherein

    • Q is the product formed from polyisocyanate;
    • W is the product formed from polycarbonate polyol monomer;
    • V is the product formed from hydrocarbon based triol or tetraol;
    • Y is the product formed from C3-C8alkyldiol optionally substituted with —(O)OH or a mono-aminoC3-C8alkyldiol;
    • Z is the product formed from C3-C8alkyldiamine optionally substituted with —(O)OH; and
    • X is a neutralizer.


In a fourth embodiment, the polyisocyanate described in the composition of the third embodiment is selected from tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, dodecamethylene diisocyanate, cyclohexane-1,3- and -1,4-diisocyanate, 1-isocyanato-3-isocyanatomethyl-3,5,5-trimethylcyclohexane (isophorone diisocyanate or IPDI), bis-(4-isocyanatocyclohexyl)-methane, 1,3- and 1,4-bis(isocyanatomethyl)-cyclohexane, bis-(4-isocyanato-3-methyl-cyclohexyl)-methane, 1,5-diisocyanato naphthalene, 4,4′-methylenebis(cyclohexyl isocyanate) (H12MDI) and norbornene diisocyanate, wherein the remaining features are as described above in the first or second embodiment. In one alternative, the polyisocyanate described in the composition of the third embodiment is isophorone diisocyanate, wherein the remaining features are as described above in the first or second embodiment.


In a fifth embodiment, the polycarbonate polyol monomer described in the composition of the third embodiment has a molecular weight ranging from about 500 g/mol to about 4,000 g/mol, wherein the remaining features are as described above in the first, second, third, or fourth embodiment. Alternatively, the polycarbonate polyol monomer described in the composition of the third embodiment has a molecular weight ranging from about 750 g/mol to about 3,500 g/mol, wherein the remaining features are as described above in the first, second, third, or fourth embodiment. In another alternative, the polycarbonate polyol monomer described in the composition of the third embodiment has a molecular weight ranging from about 1,000 g/mol to about 3,000 g/mol, wherein the remaining features are as described above in the first, second, third, or fourth embodiment. In yet another alternative, the polycarbonate polyol monomer described in the composition of the third embodiment has a molecular weight of about 1,000 g/mol or about 2,000 g/mol or about 3,000 g/mol, wherein the remaining features are as described above in the first, second, third, or fourth embodiment.


In a sixth embodiment, Y in the composition of the third embodiment is the product formed from C3-C8alkyldiol optionally substituted with —(O)OH, wherein the remaining features are as described above in the first, second, third, fourth, or fifth embodiment. Alternatively, Y in the composition of the third embodiment is the product formed from 2,2-bis(hydroxymethyl)butyric acid, wherein the remaining features are as described above in the first, second, third, fourth, or fifth embodiment.


In a seventh embodiment, Z in the composition of the third embodiment is lysine, wherein the remaining features are as described above in the first, second, third, fourth, fifth, or sixth embodiment.


In an eighth embodiment, the neutralizer in the composition of the third embodiment is Na2CO3, triethylamine, or lactic acid, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, or seventh embodiment. Alternatively, the neutralizer in the composition of the third, fourth, fifth, sixth, or seventh embodiment is Na2CO3, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, or seventh embodiment.


In a ninth embodiment, V in the composition of the third embodiment is glycerol, trimethylol propane, erythritol, or pentaerythritol, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, or eighth embodiment. Alternatively, V in the composition of the third, fourth, fifth, sixth, or seventh embodiment is glycerol or erythritol, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, or eighth embodiment.


In a tenth embodiment, the molar ratio of W to Q in the composition of the third embodiment is about 0.2:1 to about 0.3:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, or ninth embodiment. Alternatively, the molar ratio of W to Q in the composition of the third embodiment is about 0.22:1 to about 0.3:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, or ninth embodiment.


In an eleventh embodiment, the molar ratio of V to Q in the composition of the third embodiment is about 0.10:1 to about 0.26:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, or tenth embodiment. Alternatively, the molar ratio of V to Q in the composition of the third embodiment is about 0.12:1 to about 0.24:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, or tenth embodiment.


In a twelfth embodiment, the molar ratio of Y to Q in the composition of the third embodiment is about 0.18:1 to about 0.25:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, or eleventh embodiment. Alternatively, the molar ratio of Y to Q in the composition of the third embodiment is about 0.20:1 to about 0.23:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, or eleventh embodiment.


In a thirteenth embodiment, the molar ratio of Z to Q in the composition of the third embodiment is about 0.05:1 to about 0.40:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, or twelfth embodiment. Alternatively, the molar ratio of Z to Q is about 0.11:1 to about 0.34:1, wherein the remaining features are as described above in the first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, or twelfth embodiment.


In a fourteenth embodiment, the polyurethane-urea of the first or second embodiment is of the Formula I or II:




embedded image



or




embedded image




    • or a salt thereof, wherein each R1 and R2 are independently repeating units of the formula:







embedded image



wherein n is from 6 to 21 and m is from 5 to 15.


In a fifteenth embodiment, the polyurethane-urea of the first or second embodiment is selected from any one of those described in the Exemplification section below. Both neutral and salt forms of the polyurethane-ureas are included.


In a sixteenth embodiment, the polyurethane-urea of the first embodiment is cationic.


In a seventeenth embodiment, the polyurethane-urea of the first and sixteenth embodiment is of the formula: [Q′, W′, V′, Y′ and Z′]X′, wherein

    • Q′ is the product formed from polyisocyanate;
    • W′ is the product formed from polycarbonate polyol monomer;
    • V′ is the product formed from hydrocarbon based triol or tetraol;
    • Y′ is the product formed from C1-C8alkyldiol monomer;
    • Z′ is the product formed from C1-8aminoalkyldiol monomer; and
    • X′ is a neutralizer.


In an eighteenth embodiment, the polyisocyanate in the composition of the sixteenth embodiment is isophorone diisocyanate monomer, wherein the remaining features are as described in the first or fifteenth embodiment.


In an nineteenth embodiment, Y′ in the composition of the sixteenth embodiment is the product formed from 1,4-butanediol monomer, wherein the remaining features are as described in the first, fifteenth, or eighteenth embodiment.


In a twentieth embodiment, Z′ in the composition of the sixteenth embodiment is the product formed from 3-(dimethylamino)-1,2-propanediol monomer, wherein the remaining features are as described in the first, fifteenth, eighteenth, or nineteenth embodiment.


In a twenty-first embodiment, the compositions described in any one of the first to twentieth embodiment, further comprise nanoparticles.


In a twenty-second embodiment, the compositions described in any one of the first to twenty-first embodiment, further comprise nanoparticles, wherein the nanoparticles are incorporated into the polyurethane-urea (e.g., through in situ polymerization).


In a twenty-third embodiment, the compositions described in any one of the first to twenty-second embodiment, further comprise nanoparticles, wherein the nanoparticles are post-blended with the composition.


In a twenty-fourth embodiment, the nanoparticles described in any one of the twentieth to twenty-third embodiments are fumed silica or titanium dioxide nanoparticles.


In a twenty-fifth embodiment, also provided herein is a hair treatment composition comprising a polyurethane-urea and at least one nanoparticle, wherein the Young's modulus of the polyurethane-urea is above 150 MPa; the elongation at break of the polyurethane-urea is from about 15% to about 300%; and the moisture uptake of the polyurethane-urea is less than 10%. In one aspect, the at least one nanoparticle of this embodiment is incorporated into the polyurethane-urea (e.g., through in situ polymerization). Alternatively, the at least one nanoparticle of this embodiment is post-blended with the composition. The nanoparticle described in this embodiment may be fumed silica or titanium dioxide nanoparticle.


In a twenty-sixth embodiment, the polyurethane-urea of the twenty-fifth embodiment is selected from any one of those described in the Exemplification section below. Both neutral and salt forms of the polyurethane-ureas are included.


The compositions described herein may further comprise oils. Oils for use in the disclosed compositions can be selected from mineral, animal, plant or synthetic oils. In one aspect, the oil is linoleic acid or a mixture of fatty acids. Examples include, but are not limited to fragrance oils, emollients, monoterpenoids, fatty alcohols, fatty acids, fatty esters, fatty ethers, fluorinated small molecules (e.g., perfluoromethylcyclopentane, perfluoroperhydrophenanthrene, perfluoro-1,3-dimethylcyclohexane, perfluoromethyldecalin, and perfluoroperhydrobenzyl-tetralin), and mixtures thereof. In another aspect, the oil is present in an amount ranging from about 0.2 to about 1.65% based on the total weight of the composition. In another aspect, the oil is present in an amount of about 0.2 to about 0.25% based on the total weight of the composition.


In one aspect, the disclosed compositions are applied to the hair with water.


In one aspect, the disclosed compositions, when applied to the hair, change the texture and appearance.


In one aspect, the disclosed compositions, when applied to the hair, improve hold, i.e., hair that is formed into a given curl or style retains that curl or style over time.


In one aspect, the disclosed compositions, when applied to the hair, provide sufficient stylability, i.e., the composition applied to hair supplies sufficient rigidity and flexibility to form and maintain a style.


In one aspect, the disclosed compositions, when applied to the hair, minimize flyaways, i.e., there are minimal individual hair fibers that do not conform to the given curl or style.


In one aspect, the disclosed compositions, when applied to the hair, preserves curl shape, i.e., hair that is formed into a given curl retains that curl over time.


In one aspect, the disclosed compositions, when applied to the hair, provides natural curl enhancement, i.e., hair that naturally tends to curl displays a more defined and less diffused curl pattern.


The compositions described herein may further comprise an antioxidant. Antioxidants that may be suitable with the compositions described herein include, but are not limited to, açai oil, alpha lipoic acid, green and white tea, retinol, vitamin C, Vitamin E, butylated hydroxytoluene, butylated hydroxyanisole, coenzyme Q10 (Co Q-10), isoflavones, polyphenols, curcumin, turmeric, pomegranate, rosemary, glutathione, selenium, and zinc.


4. Methods of Use

The compositions described herein may be used for any cosmetic application. Such applications include, but are not limited to, skin-care creams, eye and facial makeup (e.g., mascara, eye liner, eyebrow makeup, and the like), deodorants, lotions, powders, perfumes, baby products, body butters; and hair products (e.g., permanent chemicals, hair colors, hair sprays, and gels).


In one aspect, the compositions described herein are used as a hair product, e.g., in a conventional manner for providing hairstyle/hold benefits.


In an exemplary aspect, an effective amount of a composition described herein may be sprayed or applied onto dry or damp hair before and/or after the hair is styled. As used herein “effective amount” means an amount sufficient to provide the hair hold and style performance desired according to the length and texture of the hair.


In one aspect, the present disclosure provides a method of fixing hair comprising the step of applying a polyurethane disclosed herein. In one aspect, the present disclosure provides a method of retaining the curl of hair comprising the step of applying polyurethane disclosed herein.


In one aspect, the present disclosure also includes a method to determine the curl retention of a hair tress. In one aspect, the method of measuring the curl retention of a hair tress includes the steps of a) measuring the length of the hair tress; b) applying a composition disclosed herein to the hair tress; c) blow drying the hair tress without brushing; d) curling the hair tress with a heated curling rod; e) mechanically manipulating the hair tress by pulling, combing and brushing; and f) measuring the length of the curled hair tress.


In one aspect, the method of measuring the curl retention of a hair tress, includes the steps of a) measuring the length of the hair tress; b) applying a composition described herein to the hair tress; c) blow drying the hair tress without brushing; d) curling the hair tress heated curling rod; e) subjecting the hair tress to humidity; and f) measuring the length of the curled hair tress. In one aspect, the curled hair tress is subjected to 60%, 70%, 75%, 80% or 90% relative humidity for 3, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 75, 90, 105, 120, 180 or 210 minutes at a temperature of 25° C.


EXEMPLIFICATION
Example 1. Methods for Determining Mechanical Performance

The Young's modulus is a measure of the ability of a material to withstand changes in length when under uniaxial tension or compression. A higher Young's modulus typically indicates that the material is more rigid. The elongation at break, also known as fracture strain, is the ratio between changed length and initial length after breakage of the test specimen. A higher elongation at break expresses the capability of a material to resist fracture. For a composition applied to hair to hold the shape of the hair, the Young's modulus and elongation at break of the composition should be such that the composition provides rigidity to the hair but is not brittle.


A comparison of Young's modulus and the elongation at break for the some of the polyurethanes disclosed herein was made to several commercially available polyurethane products. The Young's modulus and the elongation at break can be determined by a protocol defined to measure mechanical properties is developed in compliance with ASTM D638, ASTM D412, test guidelines. In particular, the following protocol can be used to determine the Young's modulus and elongation at break (or ultimate elongation) of dry film of polyurethanes. Testing requires approximately 10-20 min per sample to complete.


Materials:

    • >25 g polyurethane aqueous dispersion
    • 1 clean rectangular mold (2 mm×20 mm×45 mm) grooved on Teflon sheet per sample
    • 1 clean razor blade
    • Scotch tape
    • Universal Testing Machine mounted with extension grip geometry


Sample Preparation:

    • 1. Prepare 25 g of 10 wt % WBPU solution from their respective stock solution.
    • 2. Apply 2.5 mL prepared solution in each mold (2 mm×20 mm×45 mm) and allow drying for 2 days to give WBPU film.
    • 3. After it dries out, use a spatula to remove film from the mold.
    • 4. Use the razor blade to cut corners and get film with around 15 mm width and around 150-300 micron thickness. Make sure that the film is free of air bubbles.
    • 5. Label the test film.
    • 6. Cut four pieces of tape (20 mm) per sample and adhere them to both sides of the specimen strip and make a dog-bone shaped sample to improve hold of sample in grip. Store the prepared test films in desiccators for 1-2 hour to fully dry them. Take one sample out of desiccators at a time for testing.


Sample Testing

    • 1. Balance the load registering on the universal testing machine so that it reads 0 Newtons.
    • 2. Use calipers to set a distance of 20 mm between the top and bottom extension grip geometries.
    • 3. Mount a sample in the extension grips and secure tightly, ensuring that the scotch tape is not visible, and that the sample is as close to vertical as possible in both vertical planes.
    • 4. Stretch the sample slightly, by separating the geometries until a force of 25 N is registered.
    • 5. Begin a tensile testing run on the universal testing machine at a speed of 100 mm/minute, stopping the test upon sample fracture.
    • 6. Elongation at break is calculated at the elongation at which the material fractures.
    • 7. Young's modulus is calculated as the modulus during the initial, elastic portion of deformation by calculating the slope of a linear fit to that region with an R value >0.99.
    • a) low modulus and high elongation (Avalure UR 450, C1004, Polyderm PE/PA ED, Polyderm PE/PA), which leads to inferior curl hold (e.g., hold is temporary, transient, or short-lived) or
    • b) high modulus and low elongation (DynamX, DynamX/H2O, Luviset PUR), which leads to a brittle material with low performance (e.g., resin is brittle or fractures) after manipulation.


Example 2. Methods for Determining Hydrophobicity/Water Uptake

The moisture uptake properties, under highly humid environment, of WBPU dry films have been linked to their long lasting hold performance. As such, it is important to be able to reproducibly and accurately evaluate such moisture uptake properties to enable predictive in vitro and in vivo evaluation of WBPU dry films. The following protocol can be used to determine moisture uptake ability of WBPU dry films under high humid environment. Test requires about 2-3 days per sample set to complete


Materials

    • >15 g WBPU solution
    • 1 clean cell culture petri dish (60 mm dia×15 mm H) per sample
    • Humidity chamber with flexibility to control temperature and relative humidity (RH)


Sample Testing

    • 1. Prepare 15 g of 10 wt % WBPU solution from their respective stock solution.
    • 2. Label cell culture petri dishes for each sample and measure their empty weight (Wpd).
    • 3. Apply 4 mL prepared solution in each petri dish (3 samples per WBPU and allow to equilibrate for 20 hours at 25° C. and 50% RH in humidity chamber.
    • 4. After equilibration, measure and record sample weight (Wi).
    • 5. Place the samples to humidity chamber at 25° C. and 90% RH and allow equilibration to high humidity for 20 hours.
    • 6. Measure and record final sample weight (Wf).


Sample Analysis


Calculate % moisture uptake using the following equation:







%


moisture


uptake

=


[


(


(

Wf
-
Wpd

)

-

(

Wi
-
Wpd

)


)


(

Wi
-
Wpd

)


]

×
1

0

0

%





Example 3. Compositions and Properties of WBPU-Us Having Chain Extenders or Nanoparticles Through In Situ Polymerization

Compositions comprising a polyurethane-urea crosslinked by at least one hydrocarbon based triol or tetraol were formulated by water or mixture of water and ethanol. The ratio of the constituents in the final blend is listed in Table 1


















TABLE 1








Alcohols
Ionic
Non-ionic









chain
chain
chain
Weight







Polyol
extender
extender
extender
percent







(molar
(molar
(molar
(molar
of

Degree



PU

ratio to
ratio to
ratio to
ratio to
fumed

of



Name
NCO
NCO)
NCO)
NCO)
NCO)
silica
Neut.
Neut.
Oil







419
IPDI
PCD1K
Glycerol
DMBA
LL (0.20)
NP
Na2CO3
100%
NP




(0.30)
(0.18)
(0.23)







420
IPDI
PCD1K
Erythritol
DMBA
LL (0.20)
NP
Na2CO3
100%
NP




(0.30)
(0.14)
(0.23)







424
IPDI
PCD1K
Erythritol
DMBA
LL (0.34)
NP
Na2CO3
100%
NP




(0.22)
(0.12)
(0.20)







425
IPDI
PCD1K
Erythritol
DMBA
LL (0.11)
NP
Na2CO3
100%
NP




(0.22)
(0.24)
(0.20)







426
IPDI
PCD1K
Erythritol
DMBA
LL (0.27)
NP
Na2CO3
100%
NP




(0.26)
(0.13)
(0.21)







427
IPDI
PCD1K
BD
DMBA
LL (0.19)
1%
Na2CO3
100%
Mixture




(0.31)
(0.27)
(0.23)




of FAs


428
IPDI
PCD1K
BD
DMBA
LL (0.19)
5%
Na2CO3
100%
Mixture




(0.30)
(0.27)
(0.23)




of FAs





IPDI = isophorone diisocyanate; PCD1K = polycarbonate diol with molecular weight at 1,000 g/mol; BD = 1,4-butanediol; DMBA = 2,2-bis(hydroxymethyl)butyric acid; LL = L-lysine; and FA = fatty acids.


NP = not present






Of the compositions listed in Table 1, PU 420, 424, 425, 426, and 428 have an elongation at break lower than 15%, are therefore considered to be compositions with suboptimal mechanical properties. Those having mechanical properties within the disclosed ranges are shown in Table 2.












TABLE 2





PU
Young's
Elongation
Water


Name
Modulus (MPa)
at break (%)
Uptake (%)







*339
388 ± 23
14 ± 5
 5.6 ± 0.44


(Comparator 1)





419
407 ± 77
12 ± 4
5.62 ± 1.05


427
349 ± 28
20 ± 9
8.73 ± 0.39





*PU 339 comprises polycarbonate polyol, IPDI, DMBA, 1,4-BD, LL, and fatty acid, i.e., No hydrocarbon based triol or tetraol was used.







FIG. 2 shows the in vitro performance of the WBPU/silica nanocomposite PU 427 compared to a commercial resin and comparator PU 339. As shown, PU 427 showed better initial hold as well as stronger humidity resistance. In an in vivo mannequin head test, PU 427 also demonstrated better curl retention than PU 339 under 90% humidity for 3 min. See FIG. 3.


Example 4. Nanoparticle Post-Blending Incorporation

The incorporation of nanoparticles to WBPU compositions having the disclosed properties was investigated. Fumed silica and titanium dioxide (TiO2) were explored. As shown in Table 3, when fumed silica nanoparticles, Aerosil 200 and Aerosil 300 (Evonik) were incorporated through post-blending, PU 339 showed improved mechanical properties. With increasing fumed silica concentration from 1% to 10% (with respect to waterborne polyurethane solid content), Young's modulus increased significantly; elongation at break, on the other hand, remained similar as that for PU 339. All WBPU/fumed silica nanocomposites showed low water uptake, i.e., 5.4-6.9%.














TABLE 3






Fumed
Loading
Young's
Elongation at
Water


WBPU
Silica
conc.
modulus (MPa)
break (%)
uptake (%)







PU 339


388 ± 23
14 ± 5
 5.6 ± 0.44



Aerosil
 1%
436 ± 3 
11 ± 3
 6.9 ± 0.35



200
 5%
499 ± 23
14 ± 4
6.69 ± 0.27




10%
508 ± 13
10 ± 4
N/A



Aerosil
 1%
393 ± 14
 8 ± 5
5.79 ± 0.26



300
 5%
451 ± 13
12 ± 3
5.39 ± 0.09




10%
535 ± 24
10 ± 3
N/A









Titanium dioxide (TiO2) nanoparticles were also incorporated into PU 339 through post-blending. In Table 4, the results show a significant increase of Young's modulus when 0.25% (with respect to waterborne polyurethane solid content) of TiO2 was post-blended into WBPU, similar to the WBPU/fumed silica systems (Table 3). Conversely, increasing loading concentration of TiO2 from 0.25% to 0.5% or 1% did not further enhance mechanical properties of WBPU. In vitro testing shows that, when 1% Aerosil 200 or 0.25% TiO2 was post-blended in PU 339, both initial curl hold and curl retention after high humidity stress were improved; moreover, the post-blended WBPU nanocomposites as well as PU 339 all performed much better than commercial resin (FIG. 4). All WBPU/TiO2 nanocomposites showed low water uptake, i.e., around 6.7%.














TABLE 4








Young's
Elongation
Water



Nano-
Loading
modulus
at break
uptake


WBPU
particles
conc.
(MPa)
(%)
(%)







PU 339


388 ± 23
14 ± 5
5.6 ± 0.44



TiO2
0.25%
500 ± 23
15 ± 5
6.7 ± 0.33




 0.5%
503 ± 32
 23 ± 12
N/A




   1%
510 ± 26
12 ± 8
6.7 ± 0.15









As previously described, compositions comprising WBPUs having a Young's modulus above 150 MPa, an elongation at break from about 15% to about 300%, and a moisture uptake of less than 10%, provide long-lasting and natural hairstyles. The above data establishes that cross-linking these WBPUs with at least one hydrocarbon based triol or tetraol leads to hair compositions with better hold and stronger humidity resistance. The above data also establishes that incorporating nanoparticles into WBPU-based compositions possessing the proper combination of mechanical properties further enhance the long-lasting characteristic of WBPUs in hair treatment products.


The contents of all references (including literature references, issued patents, published patent applications, and co-pending patent applications) cited throughout this application are hereby expressly incorporated herein in their entireties by reference. Unless otherwise defined, all technical and scientific terms used herein are accorded the meaning commonly known to one with ordinary skill in the art.

Claims
  • 1. A hair treatment composition comprising a polyurethane-urea crosslinked by at least one hydrocarbon based triol or tetraol, wherein the polyurethane-urea is a salt of the formula: [Q, W, V, Y and Z]X, wherein Q is the product formed from polyisocyanate;W is the product formed from polycarbonate polyol monomer;V is the product formed from hydrocarbon based triol or tetraol;Y is the product formed from C3-C8alkyldiol optionally substituted with —C(O)OH or a mono-aminoC3-C8alkyldiol;Z is the product formed from C3-C8alkyldiamine optionally substituted with —C(O)OH; andX is a neutralizer;
  • 2. The composition of claim 1, wherein the polyurethane-urea is anionic.
  • 3. The composition of claim 1, wherein the polyisocyanate is selected from tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, dodecamethylene diisocyanate, cyclohexane-1,3- and -1,4-diisocyanate, 1-isocyanato-3-isocyanatomethyl-3,5,5-trimethylcyclohexane (isophorone diisocyanate or IPDI), bis-(4-isocyanatocyclohexyl)-methane, 1,3- and 1,4-bis(isocyanatomethyl)-cyclohexane, bis-(4-isocyanato-3-methyl-cyclohexyl)-methane, 1,5-diisocyanato naphthalene, 4,4′-methylenebis(cyclohexyl isocyanate) (H12MDI) and norbornene diisocyanate.
  • 4. The composition of claim 1, wherein the polycarbonate polyol monomer has a molecular weight ranging from about 500 g/mol to about 4,000 g/mol.
  • 5. The composition of claim 1, wherein Y is the product formed from C3-C8alkyldiol optionally substituted with —(O)OH.
  • 6. The composition of claim 1, wherein Z is lysine.
  • 7. The composition of claim 1, wherein the neutralizer is Na2CO3, triethylamine, or lactic acid.
  • 8. The composition of claim 1, wherein V is glycerol, trimethylol propane, erythritol, or pentaerythritol.
  • 9. The composition of claim 1, wherein the molar ratio of W to Q is about 0.2:1 to about 0.3:1.
  • 10. The composition of claim 1, wherein the molar ratio of V to Q is about 0.10:1 to about 0.26:1.
  • 11. The composition of claim 1, wherein the molar ratio of Y to Q is about 0.18:1 to about 0.25:1.
  • 12. The composition of claim 1, wherein the molar ratio of Z to Q is about 0.05:1 to about 0.40:1.
  • 13. The composition of claim 1, wherein the polyurethane-urea is of the Formula I or II:
  • 14. The composition of claim 1, wherein the composition further comprises nanoparticles.
  • 15. A method of preserving curl in human hair, said method comprising administering to the hair a composition according to claim 1.
PCT Information
Filing Document Filing Date Country Kind
PCT/US2019/029274 4/26/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/210121 10/31/2019 WO A
US Referenced Citations (299)
Number Name Date Kind
3104424 Immel Sep 1963 A
3262686 Kraus et al. Jul 1966 A
3803063 Krentz, Jr. Apr 1974 A
3973901 Micchelli et al. Aug 1976 A
4071614 Grimm, III Jan 1978 A
4455146 Noda et al. Jun 1984 A
4950542 Barker Aug 1990 A
5110852 Gogolewski et al. May 1992 A
5281654 Eisenhart et al. Jan 1994 A
5290543 Ounanian et al. Mar 1994 A
5335373 Dresdner, Jr. et al. Aug 1994 A
5354807 Dochniak Oct 1994 A
5357636 Dresdner, Jr. et al. Oct 1994 A
5362486 Nandagiri et al. Nov 1994 A
5534265 Fowler et al. Jul 1996 A
5534348 Miller et al. Jul 1996 A
5540853 Trinh et al. Jul 1996 A
5626840 Thomaides et al. May 1997 A
5637291 Bara et al. Jun 1997 A
5643581 Mougin et al. Jul 1997 A
5720961 Fowler et al. Feb 1998 A
5733572 Unger et al. Mar 1998 A
5807540 Junino et al. Sep 1998 A
5833967 Ramin Nov 1998 A
5846551 DaCunha et al. Dec 1998 A
5849310 Trinh et al. Dec 1998 A
5891463 Bello et al. Apr 1999 A
5900457 Duan et al. May 1999 A
5912299 Tomko et al. Jun 1999 A
5914117 Lavaud Jun 1999 A
5932194 Plessix et al. Aug 1999 A
5932200 Reich et al. Aug 1999 A
5993972 Reich et al. Nov 1999 A
6007793 Bhatt et al. Dec 1999 A
6084051 Blum et al. Jul 2000 A
6086903 Trinh et al. Jul 2000 A
6106813 Mondet et al. Aug 2000 A
6126930 Dubois et al. Oct 2000 A
6130309 Reich et al. Oct 2000 A
6132704 Bhatt et al. Oct 2000 A
6153179 Blankenburg et al. Nov 2000 A
6156325 Farer et al. Dec 2000 A
6221344 Ramin et al. Apr 2001 B1
6238651 Bara May 2001 B1
6254876 de la Poterie et al. Jul 2001 B1
6277386 Kim et al. Aug 2001 B1
6277401 Bello et al. Aug 2001 B1
6291580 Kukkala et al. Sep 2001 B1
6298558 Tseng et al. Oct 2001 B1
6319959 Mougin et al. Nov 2001 B1
6326013 Lemann et al. Dec 2001 B1
6346234 Rollat et al. Feb 2002 B1
6361782 Chevalier et al. Mar 2002 B1
6365697 Kim et al. Apr 2002 B1
6372876 Kim et al. Apr 2002 B1
6403070 Pataut et al. Jun 2002 B1
6403107 Lemann Jun 2002 B1
6403542 Maurin et al. Jun 2002 B1
6409998 Candau et al. Jun 2002 B1
6433073 Kantner et al. Aug 2002 B1
6465534 Fukuzawa et al. Oct 2002 B2
6469227 Cooke et al. Oct 2002 B1
6485950 Kumar et al. Nov 2002 B1
6517821 Rollat et al. Feb 2003 B1
6520186 Rollat et al. Feb 2003 B2
6524564 Kim et al. Feb 2003 B1
6524597 Kashimoto Feb 2003 B2
6531118 Gonzalez et al. Mar 2003 B1
6555096 Carrion et al. Apr 2003 B2
6576024 Lang et al. Jun 2003 B1
6576702 Anderle et al. Jun 2003 B2
6579517 Kim et al. Jun 2003 B1
6592881 Fukuda et al. Jul 2003 B1
6613314 Rollat et al. Sep 2003 B1
6635262 Jourdan et al. Oct 2003 B2
6641804 Ohta et al. Nov 2003 B1
6682748 De La Poterie et al. Jan 2004 B1
6689345 Jager Lezer Feb 2004 B2
6692729 Asaoka et al. Feb 2004 B1
6719959 Gonzalez et al. Apr 2004 B1
6730289 Khoshdel May 2004 B2
6750291 Kim et al. Jun 2004 B2
6800276 Kim et al. Oct 2004 B2
6830758 Nichols et al. Dec 2004 B2
6884853 Asaoka et al. Apr 2005 B1
6897281 Lubnin et al. May 2005 B2
6927254 Melchiors et al. Aug 2005 B2
7019061 Meffert et al. Mar 2006 B2
7098178 Gerke et al. Aug 2006 B2
7101954 Zofchak et al. Sep 2006 B2
7160553 Gibbins et al. Jan 2007 B2
7326256 Cottard et al. Feb 2008 B2
7348299 Keenan et al. Mar 2008 B2
7445770 Berezkin et al. Nov 2008 B2
7452525 Berezkin et al. Nov 2008 B1
7481996 Ishii et al. Jan 2009 B2
7659233 Hurley et al. Feb 2010 B2
7700082 Mallo et al. Apr 2010 B2
7740832 Rollat-Corvol et al. Jun 2010 B1
7744911 Pechko et al. Jun 2010 B2
RE41615 Kim et al. Aug 2010 E
7829099 Woeller et al. Nov 2010 B2
7907346 Swarup et al. Mar 2011 B2
7914775 Cottard et al. Mar 2011 B2
7959903 Candau et al. Jun 2011 B2
7972589 Leighton et al. Jul 2011 B2
7998465 De La Poterie et al. Aug 2011 B2
8067355 Smets et al. Nov 2011 B2
8258093 Van Dyke Sep 2012 B2
8343523 Toreki et al. Jan 2013 B2
8449871 Mougin et al. May 2013 B2
8497338 Bai et al. Jul 2013 B2
8623388 Rajaiah et al. Jan 2014 B2
8629213 Hidalgo et al. Jan 2014 B2
8679050 Nakamura Mar 2014 B2
8679465 Malnou et al. Mar 2014 B2
8685377 Kaftan et al. Apr 2014 B2
8734772 Zhou et al. May 2014 B1
8741333 Zhang et al. Jun 2014 B2
8784854 Choi et al. Jul 2014 B2
8871817 Turk et al. Oct 2014 B2
8882902 Suzuki et al. Nov 2014 B2
8895040 Vondruska et al. Nov 2014 B2
8956160 Willison et al. Feb 2015 B2
8956162 De Vreese et al. Feb 2015 B2
9016221 Brennan et al. Apr 2015 B2
RE45538 Smets et al. Jun 2015 E
9079152 Markus et al. Jul 2015 B2
9101143 Markus et al. Aug 2015 B2
9102783 Yagi et al. Aug 2015 B2
9175125 Turk et al. Nov 2015 B2
9295632 Benn et al. Mar 2016 B1
9340650 Wagner et al. May 2016 B2
9393218 Zurdo Schroeder et al. Jul 2016 B2
9458354 Felice Oct 2016 B2
10842729 Kang et al. Nov 2020 B2
20010031280 Ferrari et al. Oct 2001 A1
20020028875 Anderle et al. Mar 2002 A1
20020034480 Grimm et al. Mar 2002 A1
20020034486 Midha et al. Mar 2002 A1
20020102222 Carrion et al. Aug 2002 A1
20020107314 Pinzon et al. Aug 2002 A1
20020114773 Kanji et al. Aug 2002 A1
20020155962 Cincotta et al. Oct 2002 A1
20020164297 Ferrari et al. Nov 2002 A1
20020192273 Buseman et al. Dec 2002 A1
20030026815 Scott et al. Feb 2003 A1
20030064086 Carrion et al. Apr 2003 A1
20030082126 Pinzon et al. May 2003 A9
20030086886 Midha May 2003 A1
20030086896 Midha et al. May 2003 A1
20030099694 Cevc et al. May 2003 A1
20030125427 Pinzon et al. Jul 2003 A9
20030185780 Ferrari et al. Oct 2003 A1
20030190345 Cordes et al. Oct 2003 A1
20030191154 Kalafsky et al. Oct 2003 A1
20030198659 Hoffmann et al. Oct 2003 A1
20030203991 Schottman et al. Oct 2003 A1
20040001798 Perron et al. Jan 2004 A1
20040057914 Bonda et al. Mar 2004 A1
20040071757 Rolf Apr 2004 A1
20040086482 Zofchak et al. May 2004 A1
20040120915 Yang et al. Jun 2004 A1
20040131573 Tang Jul 2004 A1
20040137028 de la Poterie Jul 2004 A1
20040156804 Poterie et al. Aug 2004 A1
20040166076 Ferrari et al. Aug 2004 A1
20040166133 Cavazzuti et al. Aug 2004 A1
20040176487 Svedberg et al. Sep 2004 A1
20040186259 Brehm et al. Sep 2004 A1
20040197286 Robert et al. Oct 2004 A1
20040223987 Ferrari Nov 2004 A1
20040228886 Ding et al. Nov 2004 A1
20040247549 Lu et al. Dec 2004 A1
20050008667 Liechty et al. Jan 2005 A1
20050014674 Liechty et al. Jan 2005 A1
20050043209 Schmiedel et al. Feb 2005 A1
20050089540 Uchiyama et al. Apr 2005 A1
20050118126 Rollat et al. Jun 2005 A1
20050148753 Nguyen-Kim et al. Jul 2005 A1
20050163741 Zech Jul 2005 A1
20050169873 Rollat et al. Aug 2005 A1
20050169874 Zofchak et al. Aug 2005 A1
20050209428 Tamareselvy Sep 2005 A1
20050220740 Dumousseaux Oct 2005 A1
20050220741 Dumousseaux Oct 2005 A1
20050249691 Monks et al. Nov 2005 A1
20050257330 Noecker et al. Nov 2005 A1
20050276831 Dihora et al. Dec 2005 A1
20050287100 Lebre Dec 2005 A1
20050287103 Filippi et al. Dec 2005 A1
20050287182 Monks et al. Dec 2005 A1
20050287183 Lebre Dec 2005 A1
20060045890 Gonzalez et al. Mar 2006 A1
20060045893 Yu et al. Mar 2006 A1
20060051311 Walter et al. Mar 2006 A1
20060073106 Berg-Schultz et al. Apr 2006 A1
20060078519 Lion et al. Apr 2006 A1
20060083762 Brun et al. Apr 2006 A1
20060099550 Faasse et al. May 2006 A1
20060120983 Blin et al. Jun 2006 A1
20060134049 Keenan et al. Jun 2006 A1
20060171984 Cromack et al. Aug 2006 A1
20060193789 Tamarkin et al. Aug 2006 A1
20060216250 Schultz et al. Sep 2006 A1
20060233728 Sagawa et al. Oct 2006 A1
20060281650 Keenan et al. Dec 2006 A1
20060287219 Dykstra et al. Dec 2006 A1
20070032605 Harashina Feb 2007 A1
20070105977 Gabriel et al. May 2007 A1
20070167565 Rische et al. Jul 2007 A1
20070183992 Dumousseaux et al. Aug 2007 A1
20070183997 Lebre et al. Aug 2007 A9
20070189980 Zhang et al. Aug 2007 A1
20070197704 Walter et al. Aug 2007 A1
20070207222 Yu et al. Sep 2007 A1
20070251026 Lalleman et al. Nov 2007 A1
20080044373 Tekti et al. Feb 2008 A1
20080044445 Rubin Feb 2008 A1
20080045985 Gurtner et al. Feb 2008 A1
20080138368 Lezer Jun 2008 A1
20080175875 Sunkara Jul 2008 A1
20080254074 Dussaud et al. Oct 2008 A1
20090041683 Molenda et al. Feb 2009 A1
20090049623 Brown et al. Feb 2009 A1
20090056734 Bacon Mar 2009 A1
20090061004 Birkel et al. Mar 2009 A1
20090105195 O'Brien Apr 2009 A1
20090112141 Derr Apr 2009 A1
20090175928 Maier et al. Jul 2009 A1
20090196842 Zech et al. Aug 2009 A1
20090257960 Kim et al. Oct 2009 A1
20090263338 Rolland et al. Oct 2009 A1
20090285866 Afriat et al. Nov 2009 A1
20100003198 Stolmeier et al. Jan 2010 A1
20100233146 McDaniel Sep 2010 A1
20100260687 Yu et al. Oct 2010 A1
20100261629 Smets et al. Oct 2010 A1
20100297036 Feuillette Nov 2010 A1
20100325812 Panandiker et al. Dec 2010 A1
20100325813 Dykstra et al. Dec 2010 A1
20110010817 Theberge et al. Jan 2011 A1
20110027211 Viala et al. Feb 2011 A1
20110046286 Lubnin Feb 2011 A1
20110067720 Ranade et al. Mar 2011 A1
20110117042 Viala et al. May 2011 A1
20110200927 Jung et al. Aug 2011 A1
20110229430 Hawkins et al. Sep 2011 A1
20110230474 Grigorian et al. Sep 2011 A1
20110256311 Mattos, Jr. Oct 2011 A1
20110272320 Alwattari et al. Nov 2011 A1
20110274633 Vu et al. Nov 2011 A1
20120207696 van Geel et al. Aug 2012 A1
20120255574 Flohr et al. Oct 2012 A1
20130084256 Li et al. Apr 2013 A1
20130161349 Pfeiffenberger Jun 2013 A1
20130196849 Combs et al. Aug 2013 A1
20130239344 Stolarz, Jr. et al. Sep 2013 A1
20130239874 Smith et al. Sep 2013 A1
20130261255 Deyrail et al. Oct 2013 A1
20130344019 Weber et al. Dec 2013 A1
20140010776 Viala et al. Jan 2014 A1
20140044657 Kelly et al. Feb 2014 A1
20140066496 Gunari et al. Mar 2014 A1
20140086864 Ishimori et al. Mar 2014 A1
20140105846 Viala et al. Apr 2014 A1
20140142191 De La Zerda et al. May 2014 A1
20140147396 Sertchook et al. May 2014 A1
20140170327 Dombrowski et al. Jun 2014 A1
20140219927 Belluscio et al. Aug 2014 A1
20140248270 Yu et al. Sep 2014 A1
20140248340 Schwarzentruber et al. Sep 2014 A1
20140350269 Eiji Borges Sato Nov 2014 A1
20150004117 Tan et al. Jan 2015 A1
20150004200 Brown et al. Jan 2015 A1
20150007849 Cajan et al. Jan 2015 A1
20150071978 Chang Mar 2015 A1
20150118331 Boam et al. Apr 2015 A1
20150119497 Matsui et al. Apr 2015 A1
20150190450 Chang Jul 2015 A1
20150238406 Pohlmann et al. Aug 2015 A1
20150283041 Benn et al. Oct 2015 A1
20150342845 Hwang et al. Dec 2015 A1
20150344622 Mukerjee et al. Dec 2015 A1
20160001099 Castro et al. Jan 2016 A1
20160058678 Smets et al. Mar 2016 A1
20160074311 Massey-Brooker et al. Mar 2016 A1
20160143836 Hayes et al. May 2016 A1
20160175233 Benn Jun 2016 A1
20160175238 Shin et al. Jun 2016 A1
20160184195 Tan et al. Jun 2016 A1
20160220475 Scherner et al. Aug 2016 A1
20170216188 Bermudez Agudelo et al. Aug 2017 A1
20170258700 Kang et al. Sep 2017 A1
20180000699 Trahan Jan 2018 A1
20190076347 Kang et al. Mar 2019 A1
20190151221 Kang et al. May 2019 A1
20190359786 Trahan et al. Nov 2019 A1
20220105021 Kang et al. Apr 2022 A1
Foreign Referenced Citations (212)
Number Date Country
PI0405064 Aug 2005 BR
102013022835 Aug 2015 BR
1236783 Dec 1999 CN
1370063 Sep 2002 CN
1370185 Sep 2002 CN
1413102 Apr 2003 CN
1476320 Feb 2004 CN
1487962 Apr 2004 CN
1607934 Apr 2005 CN
1650840 Aug 2005 CN
1708524 Dec 2005 CN
1775826 May 2006 CN
101124256 Feb 2008 CN
101130082 Feb 2008 CN
101361701 Feb 2009 CN
101484130 Jul 2009 CN
101980691 Feb 2011 CN
102015803 Apr 2011 CN
102575051 Jul 2012 CN
102895164 Jan 2013 CN
103314025 Sep 2013 CN
103705401 Apr 2014 CN
104188877 Dec 2014 CN
105213260 Jan 2016 CN
105561841 May 2016 CN
105764484 Jul 2016 CN
109071750 Dec 2018 CN
102015204154 Sep 2016 DE
727981 Aug 1996 EP
746377 Dec 1996 EP
789550 Aug 1997 EP
923927 Jun 1999 EP
1058560 Dec 2000 EP
1082953 Mar 2001 EP
1090632 Apr 2001 EP
1090633 Apr 2001 EP
1092419 Apr 2001 EP
1155676 Nov 2001 EP
1161937 Dec 2001 EP
1216690 Jun 2002 EP
1218430 Jul 2002 EP
1289363 Mar 2003 EP
1417886 May 2004 EP
1419759 May 2004 EP
1440680 Jul 2004 EP
1481661 Dec 2004 EP
1491179 Dec 2004 EP
1579841 Sep 2005 EP
1579849 Sep 2005 EP
1598046 Nov 2005 EP
1604634 Dec 2005 EP
1707182 Oct 2006 EP
1707183 Oct 2006 EP
1773906 Apr 2007 EP
1800671 Jun 2007 EP
1903065 Mar 2008 EP
2209472 Jul 2010 EP
2271304 Jan 2011 EP
2391424 Dec 2011 EP
2591772 May 2013 EP
2611466 Jul 2013 EP
2726067 May 2014 EP
2858630 Apr 2015 EP
2859794 Apr 2015 EP
2867298 May 2015 EP
2925296 Oct 2015 EP
2995217 Mar 2016 EP
3020454 May 2016 EP
2801209 May 2001 FR
2815350 Apr 2002 FR
2816834 May 2002 FR
2835529 Aug 2003 FR
2892931 May 2007 FR
2902655 Dec 2007 FR
2940093 Jun 2010 FR
2957347 Sep 2011 FR
2967062 May 2012 FR
H06362 Jan 1994 JP
H1080973 Mar 1998 JP
2002-020451 Jan 2002 JP
2003-081742 Mar 2003 JP
2004-203917 Jul 2004 JP
2004-256694 Sep 2004 JP
2006-290845 Oct 2006 JP
2009-292854 Dec 2009 JP
2010-132568 Jun 2010 JP
2010-163389 Jul 2010 JP
2011-173851 Sep 2011 JP
2011-246352 Dec 2011 JP
2012-057110 Mar 2012 JP
2013-502494 Jan 2013 JP
2016-094362 May 2016 JP
20080064230 Jul 2008 KR
20090058294 Jun 2009 KR
20090081582 Jul 2009 KR
20110062277 Jun 2011 KR
20140078356 Jun 2014 KR
20140093349 Jul 2014 KR
20140121154 Oct 2014 KR
1989007959 Sep 1989 WO
1991001970 Feb 1991 WO
199413354 Jun 1994 WO
199813025 Apr 1998 WO
199826751 Jun 1998 WO
199826756 Jun 1998 WO
199912519 Mar 1999 WO
199955288 Nov 1999 WO
199955290 Nov 1999 WO
199955291 Nov 1999 WO
199955292 Nov 1999 WO
199956708 Nov 1999 WO
200014091 Mar 2000 WO
2000016752 Mar 2000 WO
2000018367 Apr 2000 WO
2000027350 May 2000 WO
200040628 Jul 2000 WO
2001003652 Jan 2001 WO
2001024768 Apr 2001 WO
2001068037 Sep 2001 WO
2001078691 Oct 2001 WO
2001087065 Nov 2001 WO
2001094438 Dec 2001 WO
2002007699 Jan 2002 WO
2002039961 May 2002 WO
2002039964 May 2002 WO
2002043490 Jun 2002 WO
2002043491 Jun 2002 WO
2002045663 Jun 2002 WO
2002047620 Jun 2002 WO
2002047624 Jun 2002 WO
2002047626 Jun 2002 WO
2002047628 Jun 2002 WO
2002047657 Jun 2002 WO
2002047658 Jun 2002 WO
2002054997 Jul 2002 WO
2002055034 Jul 2002 WO
2002072045 Sep 2002 WO
2003028678 Apr 2003 WO
2003094870 Nov 2003 WO
2004110401 Dec 2004 WO
2005014777 Feb 2005 WO
2005017134 Feb 2005 WO
2005092963 Oct 2005 WO
2006015718 Feb 2006 WO
2006062740 Jun 2006 WO
2006127883 Nov 2006 WO
2006131403 Dec 2006 WO
2007057059 May 2007 WO
2007070643 Jun 2007 WO
2007071886 Jun 2007 WO
2007077029 Jul 2007 WO
2007145395 Dec 2007 WO
2008006677 Jan 2008 WO
2008006687 Jan 2008 WO
2008024408 Feb 2008 WO
2008125406 Oct 2008 WO
2008133982 Nov 2008 WO
2008148809 Dec 2008 WO
2009014347 Jan 2009 WO
2009053594 Apr 2009 WO
2010003138 Jan 2010 WO
2010006442 Jan 2010 WO
2010037402 Apr 2010 WO
2010076483 Jul 2010 WO
2010079468 Jul 2010 WO
2010086754 Aug 2010 WO
2010129299 Nov 2010 WO
2011016140 Feb 2011 WO
2011016531 Feb 2011 WO
2011022582 Feb 2011 WO
2011075556 Jun 2011 WO
2011089709 Jul 2011 WO
2011126978 Oct 2011 WO
2011140330 Nov 2011 WO
2012037445 Mar 2012 WO
2012063947 May 2012 WO
2012087510 Jun 2012 WO
2012105096 Aug 2012 WO
2012117013 Sep 2012 WO
2012121704 Sep 2012 WO
2012168102 Dec 2012 WO
2013064596 May 2013 WO
2013068478 May 2013 WO
2013071079 May 2013 WO
2013149323 Oct 2013 WO
2013165424 Nov 2013 WO
2014001574 Jan 2014 WO
2014001985 Jan 2014 WO
2014014139 Jan 2014 WO
2014105676 Jul 2014 WO
2014111579 Jul 2014 WO
2014176515 Oct 2014 WO
2014210117 Dec 2014 WO
2015020060 Feb 2015 WO
2015028417 Mar 2015 WO
2015028418 Mar 2015 WO
2015028421 Mar 2015 WO
2015028424 Mar 2015 WO
2015051139 Apr 2015 WO
2015188335 Dec 2015 WO
2016016315 Feb 2016 WO
2016058958 Apr 2016 WO
2016069396 May 2016 WO
2016074683 May 2016 WO
2016087948 Jun 2016 WO
2016096928 Jun 2016 WO
2016100885 Jun 2016 WO
2016115257 Jul 2016 WO
2016138249 Sep 2016 WO
WO-2017112521 Jun 2017 WO
2017155906 Sep 2017 WO
2019210121 Oct 2019 WO
Non-Patent Literature Citations (32)
Entry
U.S. Appl. No. 15/451,897, filed Mar. 7, 2017, 2017-0258700, Published.
U.S. Appl. No. 16/348,644, filed May 9, 2019, 2019-0359786, Abandoned.
U.S. Appl. No. 16/128,620, filed Sep. 12, 2018, U.S. Pat. No. 10,987,300, Issued.
U.S. Appl. No. 17/231,587, filed Apr. 15, 2021, Abandoned.
U.S. Appl. No. 17/530,662, filed Nov. 19, 2021, Pending.
U.S. Appl. No. 16/128,622, filed Sep. 12, 2018, U.S. Pat. No. 10,842,729, Issued.
U.S. Appl. No. 17/071,198, filed Oct. 15, 2020, Abandoned.
U.S. Appl. No. 17/326,605, filed May 21, 2021, 2022-0105021, Published.
U.S. Appl. No. 16/195,584, filed Nov. 19, 2018, 2019-0151221, Published.
Rahman, Synthesis and properties of waterborne polyurethane adhesives: effect of chain extender of ethylene diamine, butfanediol, and fluoro-butanediol. Journal of Adhesion Science and Technology. 2013;27(23):2592-2602.
U.S. Appl. No. 15/451,897, filed Mar. 7, 2017, U.S. Pat. No. 11,622,929, Issued.
U.S. Appl. No. 18/114,425, filed Feb. 27, 2023, Pending.
U.S. Appl. No. 17/530,662, filed Nov. 19, 2021, Abandoned.
U.S. Appl. No. 17/855,239, filed Jun. 30, 2022, Abandoned.
U.S. Appl. No. 18/168,215, filed Feb. 13, 2023, Pending.
Ma et al., Synthetic Leather Chemistry and Technology, 1st Edition. 4 pages, Nov. 30, 2015.
Chinese Office Action for Application No. 201980028764.2, dated Dec. 6, 2022, 17 pages.
Xu et al., Synthesis and Characterization of Cationic Waterborne Polyurethane based Polycarbonate Polyol. China Leather. Nov. 2011;40(21):1-14.
Yao et al., Application of bionic technology in textiles. Textile Dyeing and Finishing Journal. Dec. 2013;35(12):29-33.
Zhang et al., Working Manual of Large Scale Poultry Farm Laboratory. Golden Shield Publishing House. p. 138, Oct. 2013.
Chinese Office Action for Application No. 201880058933.2, dated Aug. 4, 2021, 26 pages.
U.S. Appl. No. 16/348,644, filed May 9, 2019, 2019-0359786, Published.
U.S. Appl. No. 16/128,620, filed Sep. 12, 2018, 2019-0076347, Published.
U.S. Appl. No. 17/071,198, filed Oct. 15, 2020, Pending.
Adina, Natpure Hollowbead. Adina Cosmetic Ingredients Ltd., retrieved online at: http://www.cosmeticingredients.co.uk/ingredient/natpure-hollowbead. 2 pages, (2015).
AkzoNobel, Product Specification for Expancel Microspheres. www.expancel.com, 2 pages, (2011).
Araujo et al., Techniques for reducing residual monomer content in polymers: a review. Polymer Engineering and Science. 64 pages, Jul. 1, 2002.
Lochhead et al., Polymers in Cosmetics: Recent Advances. From film-formers to rheology modifiers, polymers serve various functions. Retrieved online at: https://www.happi.com/contents/view_features/2005-11-15/polymers-in-cosmetics-recent-advances. 12 pages, Nov. 15, 2005.
Srivastava et al., Indian Application No. 148/DEL/2010. Bioreactor and Uses Thereof. Filed Jul. 29, 2011. 20 pages.
Teixeira et al., A case study of product engineering: Performance of microencapsulated perfumes on textile applications. AlChE Journal. Jun. 2011;58(6):1939-1950.
U.S. Appl. No. 17/231,587, filed Apr. 15, 2021, Pending.
U.S. Appl. No. 17/326,605, filed May 21, 2021, Pending.
Related Publications (1)
Number Date Country
20210212920 A1 Jul 2021 US